| Abstract Scope |
Localized drug delivery systems have gained significant attention due to their potential to improve therapeutic outcomes by targeting specific areas of the body while minimizing side effects. This study aims to investigate the development of a novel, physically cross-linked polymer material, utilizing Polymer-Induced Self Assembly (PISA), which can be 3D printed and tailored for localized drug delivery applications. Using reversible addition-fragment chain transfer (RAFT) polymerization, the materials degregation rate and drug encapsulation capabilities can be precisely controlled, reducing the need for invasive procedures to remove the delivery device. This research aims to enhance patient outcomes through improved drug delivery methods that are both efficient and biocompatible, providing a promising solution for localized treatment in areas such as oncology and regenerative medicine. |